Genmab A/S (NASDAQ:GMAB) Now Covered by Analysts at Redburn Atlantic

Redburn Atlantic began coverage on shares of Genmab A/S (NASDAQ:GMAB – Free Report) in a research report sent to investors on Tuesday, MarketBeat Ratings reports. The firm issued a buy rating on the stock. GMAB has been the subject of a number of other research reports. HC Wainwright restated a buy rating and issued a […]

Leave a Reply

Your email address will not be published.

Previous post Genmab A/S (NASDAQ:GMAB) Now Covered by Analysts at Redburn Atlantic
Next post Morningstar (NASDAQ:MORN) Now Covered by UBS Group